Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease
- PMID: 39614344
- PMCID: PMC11606142
- DOI: 10.1186/s40035-024-00451-8
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The studies obtained approval from respective ethics committees (Ulm University Hospital, No. 20/10; University Perugia, 19369/08/AV registry no: 1287/08 date: 9 October 2008 and University of Turin, 0114576) and adhered to the most recent iteration of the Declaration of Helsinki. Prior to participation, all the participants or their caregivers received a thorough explanation of the study's procedures and gave written consent. Consent for publication: Not applicable. Competing interests: Dr. Gaetani participated on advisory boards for, and received writing honoraria and travel grants from Almirall, Biogen, Euroimmun, Fujirebio, Lilly, Merck, Mylan, Novartis, Roche, Sanofi, Siemens Healthineers and Teva.
Figures
References
Publication types
Grants and funding
- 860197/HORIZON EUROPE Marie Sklodowska-Curie Actions
- 860197/HORIZON EUROPE Marie Sklodowska-Curie Actions
- 860197/HORIZON EUROPE Marie Sklodowska-Curie Actions
- PF-PRF-934916/Postdoctoral Fellowship for Basic Scientists grant of the Parkinson's Foundation
- PNRR-MAD-2022-12376035/European Union-Next Generation EU - PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN
- PNRR-MAD-2022-12376035/the European Union-Next Generation EU - PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN
- JCS24/02/Medical Faculty of Martin-Luther University Halle Wittenberg (Junior Clinician Scientist Programm)
- CS22/06/Medical Faculty of Martin-Luther University Halle-Wittenberg (Clinician Scientist-Programm)
LinkOut - more resources
Full Text Sources
